Skip to main content
Erschienen in: Seminars in Immunopathology 5/2015

01.09.2015 | Review

Environmental risk factors of systemic sclerosis

verfasst von: Isabelle Marie, Jean-François Gehanno

Erschienen in: Seminars in Immunopathology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Systemic sclerosis (SSc) has a complex pathogenesis. Although, there is a growing evidence that environmental factors have an impact on alterations and modulation of epigenetic determinants, resulting in SSc onset and progression. A marked correlation has thus been found between SSc onset and occupational exposure to crystalline silica and the following organic solvents: white spirit, aromatic solvents, chlorinated solvents, trichloroethylene, and ketones; the risk associated with high cumulative exposure to silica and organic solvents further appears to be strongly increased in SSc. Altogether, occupational exposure should be systematically checked in all SSc patients at diagnosis, as (1) exposed patients seem to develop more severe forms of SSc and (2) the identification of the occupational agents will allow its interruption, which may lead to potential improvement of SSc outcome. By contrast, based on current published data, there is insufficient evidence that exposure to other chemical agents (including notably pesticides as well as personal care such as silicone and hair dye), physical agents (ionizing radiation, ultraviolet radiation, electric and magnetic fields), and biological agents (infections and diet, foods, and dietary contaminants) is a causative factor of SSc. Further investigations are still warranted to identify other environmental factors that may be associated with SSc onset and progression.
Literatur
1.
Zurück zum Zitat Marie I, Antonietti M, Houivet E, Hachulla E, Maunoury V, Bienvenu B, Viennot S, Smail A, Duhaut P, Dupas JL, Dominique S, Hatron PY, Levesque H, Benichou J, Ducrotté P (2014) Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis. Aliment Pharmacol Ther 40:189–199PubMedCrossRef Marie I, Antonietti M, Houivet E, Hachulla E, Maunoury V, Bienvenu B, Viennot S, Smail A, Duhaut P, Dupas JL, Dominique S, Hatron PY, Levesque H, Benichou J, Ducrotté P (2014) Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis. Aliment Pharmacol Ther 40:189–199PubMedCrossRef
2.
Zurück zum Zitat Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13:151–156PubMedCrossRef Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13:151–156PubMedCrossRef
3.
Zurück zum Zitat Marie I, Leroi AM, Menard JF, Levesque H, Quillard M, Ducrotte P (2015) Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev 14:547–554PubMedCrossRef Marie I, Leroi AM, Menard JF, Levesque H, Quillard M, Ducrotte P (2015) Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev 14:547–554PubMedCrossRef
4.
Zurück zum Zitat Marie I, Menard JF, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Gehanno JF, Bubenheim M, Benichou J, Levesque H (2015) Association of occupational exposure with features of systemic sclerosis. J Am Acad Dermatol 72:456–464PubMedCrossRef Marie I, Menard JF, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noël D, Gehanno JF, Bubenheim M, Benichou J, Levesque H (2015) Association of occupational exposure with features of systemic sclerosis. J Am Acad Dermatol 72:456–464PubMedCrossRef
5.
Zurück zum Zitat Altorok N, Almeshal N, Wang Y, Kahaleh B (2014) Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology (Oxford) Apr 16 Altorok N, Almeshal N, Wang Y, Kahaleh B (2014) Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology (Oxford) Apr 16
7.
Zurück zum Zitat Marie I, Bény JL (2002) Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1. J Invest Dermatol 119:1379–87PubMedCrossRef Marie I, Bény JL (2002) Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1. J Invest Dermatol 119:1379–87PubMedCrossRef
8.
Zurück zum Zitat van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, York M, Collins C, Wenink M, Huijbens R, Hesselstrand R, Saxne T, DiMarzio M, Wuttge D, Agarwal SK, Reveille JD, Assassi S, Mayes M, Deng Y, Drenth JP, de Graaf J, den Heijer M, Kallenberg CG, Bijl M, Loof A, van den Berg WB, Joosten LA, Smith V, de Keyser F, Scorza R, Lunardi C, van Riel PL, Vonk M, van Heerde W, Meller S, Homey B, Beretta L, Roest M, Trojanowska M, Lafyatis R, Radstake TR (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 370:433–443PubMedCentralPubMedCrossRef van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, York M, Collins C, Wenink M, Huijbens R, Hesselstrand R, Saxne T, DiMarzio M, Wuttge D, Agarwal SK, Reveille JD, Assassi S, Mayes M, Deng Y, Drenth JP, de Graaf J, den Heijer M, Kallenberg CG, Bijl M, Loof A, van den Berg WB, Joosten LA, Smith V, de Keyser F, Scorza R, Lunardi C, van Riel PL, Vonk M, van Heerde W, Meller S, Homey B, Beretta L, Roest M, Trojanowska M, Lafyatis R, Radstake TR (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 370:433–443PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Ciechomska M, van Laar JM, O’Reilly S (2014) Emerging role of epigenetics in systemic sclerosis pathogenesis. Genes Immun 15:433–439PubMedCrossRef Ciechomska M, van Laar JM, O’Reilly S (2014) Emerging role of epigenetics in systemic sclerosis pathogenesis. Genes Immun 15:433–439PubMedCrossRef
10.
Zurück zum Zitat Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161–167PubMedCrossRef Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161–167PubMedCrossRef
11.
12.
Zurück zum Zitat Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q (2009) Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 38:369–374PubMedCrossRef Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q (2009) Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 38:369–374PubMedCrossRef
13.
Zurück zum Zitat Lian X, Xiao R, Hu X, Kanekura T, Jiang H, Li Y, Wang Y, Yang Y, Zhao M, Lu Q (2012) DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum 64:2338–2345PubMedCrossRef Lian X, Xiao R, Hu X, Kanekura T, Jiang H, Li Y, Wang Y, Yang Y, Zhao M, Lu Q (2012) DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum 64:2338–2345PubMedCrossRef
14.
Zurück zum Zitat Wang Y, Kahaleh B (2013) Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma. J Cell Mol Med 17:1291–1299PubMedCentralPubMedCrossRef Wang Y, Kahaleh B (2013) Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma. J Cell Mol Med 17:1291–1299PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Ghosh AK, Bhattacharyya S, Lafyatis R, Farina G, Yu J, Thimmapaya B, Wei J, Varga J (2013) p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis. J Invest Dermatol 133:1302–1310PubMedCentralPubMedCrossRef Ghosh AK, Bhattacharyya S, Lafyatis R, Farina G, Yu J, Thimmapaya B, Wei J, Varga J (2013) p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis. J Invest Dermatol 133:1302–1310PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Wei J, Ghosh AK, Chu H, Fang F, Hinchcliff ME, Wang J, Marangoni RG, Varga J (2015) The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor β signaling. Arthritis Rheumatol 67:1323–1334PubMedCentralPubMedCrossRef Wei J, Ghosh AK, Chu H, Fang F, Hinchcliff ME, Wang J, Marangoni RG, Varga J (2015) The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor β signaling. Arthritis Rheumatol 67:1323–1334PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat O’Reilly S, Hügle T, van Laar JM (2012) T cells in systemic sclerosis: a reappraisal. Rheumatology (Oxford) 51:1540–1549CrossRef O’Reilly S, Hügle T, van Laar JM (2012) T cells in systemic sclerosis: a reappraisal. Rheumatology (Oxford) 51:1540–1549CrossRef
18.
Zurück zum Zitat Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M, Rose NR, Gershwin ME (2012) Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 39:272–284PubMedCrossRef Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M, Rose NR, Gershwin ME (2012) Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 39:272–284PubMedCrossRef
19.
Zurück zum Zitat Takemoto R, Jinnin M, Wang Z, Kudo H, Inoue K, Nakayama W, Ichihara A, Igata T, Kajihara I, Fukushima S, Ihn H (2013) Hair miR-29a levels are decreased in patients with scleroderma. Exp Dermatol 22:832–833PubMedCrossRef Takemoto R, Jinnin M, Wang Z, Kudo H, Inoue K, Nakayama W, Ichihara A, Igata T, Kajihara I, Fukushima S, Ihn H (2013) Hair miR-29a levels are decreased in patients with scleroderma. Exp Dermatol 22:832–833PubMedCrossRef
20.
Zurück zum Zitat Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 188:3573–3583PubMedCrossRef Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 188:3573–3583PubMedCrossRef
21.
Zurück zum Zitat Jüngel A, Distler JH, Gay S, Distler O (2011) Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Rev Clin Immunol 7:475–480PubMedCrossRef Jüngel A, Distler JH, Gay S, Distler O (2011) Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Rev Clin Immunol 7:475–480PubMedCrossRef
22.
Zurück zum Zitat Bramwell B (1914) Diffuse scleroderma: its frequency and occurrence in stonemasons; its treatment by fibrinolysin: elevations of temperature due to fibrinolysin injections. Edinburg Med J 12:387 Bramwell B (1914) Diffuse scleroderma: its frequency and occurrence in stonemasons; its treatment by fibrinolysin: elevations of temperature due to fibrinolysin injections. Edinburg Med J 12:387
23.
Zurück zum Zitat Erasmus LD (1957) Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr Lab Clin Med 3:209–231 Erasmus LD (1957) Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr Lab Clin Med 3:209–231
24.
Zurück zum Zitat Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60:122–129PubMedCentralPubMedCrossRef Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60:122–129PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G (2002) Systemic sclerosis and occupational risk factors: a case–control study. Occup Environ Med 59:545–549PubMedCentralPubMedCrossRef Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G (2002) Systemic sclerosis and occupational risk factors: a case–control study. Occup Environ Med 59:545–549PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Englert H, O’connor H, Small-McMahon J, Chambers P, Davis K, Brooks P (2000) Male systemic sclerosis and occupational silica exposure—a population based study. Aust N Z J Med 30:215–220PubMedCrossRef Englert H, O’connor H, Small-McMahon J, Chambers P, Davis K, Brooks P (2000) Male systemic sclerosis and occupational silica exposure—a population based study. Aust N Z J Med 30:215–220PubMedCrossRef
27.
Zurück zum Zitat Silman AJ, Jones S (1992) What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 51:1322–1324PubMedCentralPubMedCrossRef Silman AJ, Jones S (1992) What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 51:1322–1324PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Sluis-Cremer GK, Hassel PA, Nizdo EH, Churchill AR, Zeiss EA (1985) Silica, silicosis and progressive systemic sclerosis. Br J Ind Med 41:838–843 Sluis-Cremer GK, Hassel PA, Nizdo EH, Churchill AR, Zeiss EA (1985) Silica, silicosis and progressive systemic sclerosis. Br J Ind Med 41:838–843
29.
Zurück zum Zitat Haustein UF, Ziegler V, Hermann K, Mehlhorn J, Schmidt C (1990) Silica-induced scleroderma. J Am Acad Dermatol 22:444–448PubMedCrossRef Haustein UF, Ziegler V, Hermann K, Mehlhorn J, Schmidt C (1990) Silica-induced scleroderma. J Am Acad Dermatol 22:444–448PubMedCrossRef
30.
Zurück zum Zitat Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, De Roos AJ (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259–271PubMedCentralPubMedCrossRef Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, De Roos AJ (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259–271PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Moisan S, Rucay P, Ghali A, Penneau-Fontbonne D, Lavigne C (2010) Silica-associated limited systemic sclerosis after occupational exposure to calcined diatomaceous earth. Joint Bone Spine 77:472–473PubMedCrossRef Moisan S, Rucay P, Ghali A, Penneau-Fontbonne D, Lavigne C (2010) Silica-associated limited systemic sclerosis after occupational exposure to calcined diatomaceous earth. Joint Bone Spine 77:472–473PubMedCrossRef
32.
Zurück zum Zitat Maeda M, Nishimura Y, Kumagai N, Hayashi H, Hatayama T, Katoh M, Miyahara N, Yamamoto S, Hirastuka J, Otsuki T (2010) Dysregulation of the immune system caused by silica and asbestos. J Immunotoxicol 7:268–278PubMedCrossRef Maeda M, Nishimura Y, Kumagai N, Hayashi H, Hatayama T, Katoh M, Miyahara N, Yamamoto S, Hirastuka J, Otsuki T (2010) Dysregulation of the immune system caused by silica and asbestos. J Immunotoxicol 7:268–278PubMedCrossRef
33.
Zurück zum Zitat Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M, Nakano T, Fukuoka K, Kishimoto T, Hyodoh F, Ueki A, Nishimura Y (2007) Immunological effects of silica and asbestos. Cell Mol Immunol 4:261–268PubMed Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M, Nakano T, Fukuoka K, Kishimoto T, Hyodoh F, Ueki A, Nishimura Y (2007) Immunological effects of silica and asbestos. Cell Mol Immunol 4:261–268PubMed
34.
Zurück zum Zitat Lee S, Hayashi H, Maeda M, Chen Y, Matsuzaki H, Takei-Kumagai N, Nishimura Y, Fujimoto W, Otsuki T (2012) Environmental factors producing autoimmune dysregulation—chronic activation of T cells caused by silica exposure. Immunobiology 217:743–748PubMedCrossRef Lee S, Hayashi H, Maeda M, Chen Y, Matsuzaki H, Takei-Kumagai N, Nishimura Y, Fujimoto W, Otsuki T (2012) Environmental factors producing autoimmune dysregulation—chronic activation of T cells caused by silica exposure. Immunobiology 217:743–748PubMedCrossRef
35.
Zurück zum Zitat Otsuki T, Hayashi H, Nishimura Y, Hyodo F, Maeda M, Kumagai N, Miura Y, Kusaka M, Uragami K (2011) Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int J Immunopathol Pharmacol 24:11S–16SPubMed Otsuki T, Hayashi H, Nishimura Y, Hyodo F, Maeda M, Kumagai N, Miura Y, Kusaka M, Uragami K (2011) Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int J Immunopathol Pharmacol 24:11S–16SPubMed
37.
Zurück zum Zitat Nigam SK, Suthar AM, Patel MM, Karnik AB, Dave SK, Kashyap SK, Venkaiah K (1993) Humoral immunological profile of workers exposed to asbestos in asbestos mines. Indian J Med Res 98:274–277PubMed Nigam SK, Suthar AM, Patel MM, Karnik AB, Dave SK, Kashyap SK, Venkaiah K (1993) Humoral immunological profile of workers exposed to asbestos in asbestos mines. Indian J Med Res 98:274–277PubMed
38.
Zurück zum Zitat Noonan CW, Pfau JC, Larson TC, Spence MR (2006) Nested case–control study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect 114:1243–1247PubMedCentralPubMedCrossRef Noonan CW, Pfau JC, Larson TC, Spence MR (2006) Nested case–control study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect 114:1243–1247PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Gold LS, Ward MH, Dosemeci M, De Roos AJ (2007) Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum 56:3189–3201PubMedCrossRef Gold LS, Ward MH, Dosemeci M, De Roos AJ (2007) Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum 56:3189–3201PubMedCrossRef
40.
Zurück zum Zitat Ferro A, Zebedeo CN, Davis C, Ng KW, Pfau JC (2014) Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 mice. J Immunotoxicol 11:283–290PubMedCrossRef Ferro A, Zebedeo CN, Davis C, Ng KW, Pfau JC (2014) Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 mice. J Immunotoxicol 11:283–290PubMedCrossRef
41.
Zurück zum Zitat Salazar KD, Copeland CB, Wood CE, Schmid JE, Luebke RW (2013) Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos. J Immunotoxicol 10:329–333PubMedCrossRef Salazar KD, Copeland CB, Wood CE, Schmid JE, Luebke RW (2013) Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos. J Immunotoxicol 10:329–333PubMedCrossRef
42.
Zurück zum Zitat Salazar KD, Copeland CB, Luebke RW (2012) Effects of Libby amphibole asbestos exposure on two models of arthritis in the Lewis rat. J Toxicol Environ Health 75:351–365CrossRef Salazar KD, Copeland CB, Luebke RW (2012) Effects of Libby amphibole asbestos exposure on two models of arthritis in the Lewis rat. J Toxicol Environ Health 75:351–365CrossRef
43.
Zurück zum Zitat Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6:169–175PubMedCrossRef Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6:169–175PubMedCrossRef
44.
Zurück zum Zitat Afzali B, Lombardi G, Lechler RI, Lord GM (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148:32–346PubMedCentralPubMedCrossRef Afzali B, Lombardi G, Lechler RI, Lord GM (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148:32–346PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Rodríguez-Reyna TS, Furuzawa-Carballeda J, Cabiedes J, Fajardo-Hermosillo LD, Martínez-Reyes C, Díaz-Zamudio M, Llorente L (2012) Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int 32:2653–2660PubMedCrossRef Rodríguez-Reyna TS, Furuzawa-Carballeda J, Cabiedes J, Fajardo-Hermosillo LD, Martínez-Reyes C, Díaz-Zamudio M, Llorente L (2012) Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int 32:2653–2660PubMedCrossRef
46.
Zurück zum Zitat Reinl W (1957) Sklerodermie durch trichloräthylen-einwirkung? Zent F Arbeitsmd u Arbettsschutz 7:58–60 Reinl W (1957) Sklerodermie durch trichloräthylen-einwirkung? Zent F Arbeitsmd u Arbettsschutz 7:58–60
47.
Zurück zum Zitat Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A, Biasi D, Caramaschi P (2004) A case–control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77:10–16PubMedCrossRef Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A, Biasi D, Caramaschi P (2004) A case–control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77:10–16PubMedCrossRef
48.
Zurück zum Zitat Garabrant DH, Lacey JV Jr, Laing TJ, Gillepsie BW, Mayes MD, Cooper BC (2003) Scleroderma and solvent exposure among women. Am J Epidemiol 157:493–500PubMedCrossRef Garabrant DH, Lacey JV Jr, Laing TJ, Gillepsie BW, Mayes MD, Cooper BC (2003) Scleroderma and solvent exposure among women. Am J Epidemiol 157:493–500PubMedCrossRef
49.
Zurück zum Zitat Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Toledano C, Fabre B, Fardet L, Cabane J (2007) Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case–control studies. J Rheumatol 34:97–103PubMed Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Toledano C, Fabre B, Fardet L, Cabane J (2007) Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case–control studies. J Rheumatol 34:97–103PubMed
50.
Zurück zum Zitat Maître A, Hours M, Bonneterre V, Arnaud J, Tülin-Arslan M, Carpentier P, Bergeret A, de Gaudemaris R (2004) Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 31:2395–2401PubMed Maître A, Hours M, Bonneterre V, Arnaud J, Tülin-Arslan M, Carpentier P, Bergeret A, de Gaudemaris R (2004) Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 31:2395–2401PubMed
51.
Zurück zum Zitat Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, Dosemeci M (1998) Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 41:1111–1118PubMedCrossRef Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, Dosemeci M (1998) Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 41:1111–1118PubMedCrossRef
52.
Zurück zum Zitat Cooper GS, Makris SL, Nietert PJ, Jinot J (2009) Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ Health Perspect 117:696–702PubMedCentralPubMedCrossRef Cooper GS, Makris SL, Nietert PJ, Jinot J (2009) Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ Health Perspect 117:696–702PubMedCentralPubMedCrossRef
53.
Zurück zum Zitat Khan MF, Kaphalia BS, Prabhakar BS, Kanz MF, Ansari GA (1995) Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 134:155–160PubMedCrossRef Khan MF, Kaphalia BS, Prabhakar BS, Kanz MF, Ansari GA (1995) Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 134:155–160PubMedCrossRef
54.
Zurück zum Zitat Cai P, König R, Khan MF, Kaphalia BS, Ansari GA (2007) Differential immune responses to albumin adducts of reactive intermediates of trichloroethene in MRL+/+ mice. Toxicol Appl Pharmacol 220:278–283PubMedCentralPubMedCrossRef Cai P, König R, Khan MF, Kaphalia BS, Ansari GA (2007) Differential immune responses to albumin adducts of reactive intermediates of trichloroethene in MRL+/+ mice. Toxicol Appl Pharmacol 220:278–283PubMedCentralPubMedCrossRef
55.
Zurück zum Zitat Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, Esterbauer H, Siems WG (1997) Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med 23:357–360PubMedCrossRef Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, Esterbauer H, Siems WG (1997) Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med 23:357–360PubMedCrossRef
56.
Zurück zum Zitat Halmes NC, Perkins EJ, McMillan DC, Pumford NR (1997) Detection of trichloroethylene-protein adducts in rat liver and plasma. Toxicol Lett 92:187–194PubMedCrossRef Halmes NC, Perkins EJ, McMillan DC, Pumford NR (1997) Detection of trichloroethylene-protein adducts in rat liver and plasma. Toxicol Lett 92:187–194PubMedCrossRef
57.
Zurück zum Zitat Wang G, Ansari GA, Khan MF (2007) Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene. J Toxicol Environ Health 70:1977–1985CrossRef Wang G, Ansari GA, Khan MF (2007) Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene. J Toxicol Environ Health 70:1977–1985CrossRef
58.
Zurück zum Zitat Wang G, König R, Ansari GA, Khan MF (2008) Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells. Free Radic Biol Med 44:1475–1482PubMedCentralPubMedCrossRef Wang G, König R, Ansari GA, Khan MF (2008) Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells. Free Radic Biol Med 44:1475–1482PubMedCentralPubMedCrossRef
59.
Zurück zum Zitat Wang G, Wang J, Fan X, Ansari GA, Khan MF (2012) Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+/+ mice. Toxicology 292:113–122PubMedCentralPubMedCrossRef Wang G, Wang J, Fan X, Ansari GA, Khan MF (2012) Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+/+ mice. Toxicology 292:113–122PubMedCentralPubMedCrossRef
60.
Zurück zum Zitat Shen T, Zhu QX, Yang S, Ding R, Ma T, Ye LP, Wang LJ, Liang ZZ, Zhang XJ (2007) Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes. Toxicology 239:186–194PubMedCrossRef Shen T, Zhu QX, Yang S, Ding R, Ma T, Ye LP, Wang LJ, Liang ZZ, Zhang XJ (2007) Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes. Toxicology 239:186–194PubMedCrossRef
61.
Zurück zum Zitat Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR (2000) Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 46:123–137PubMedCrossRef Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR (2000) Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 46:123–137PubMedCrossRef
62.
Zurück zum Zitat Blossom SJ, Doss JC (2007) Trichloroethylene alters central and peripheral immune function in autoimmune-prone MRL(+/+) mice following continuous developmental and early life exposure. J Immunotoxicol 4:129–141PubMedCrossRef Blossom SJ, Doss JC (2007) Trichloroethylene alters central and peripheral immune function in autoimmune-prone MRL(+/+) mice following continuous developmental and early life exposure. J Immunotoxicol 4:129–141PubMedCrossRef
63.
Zurück zum Zitat Palbykin B, Borg J, Caldwell PT, Rowles J, Papoutsis AJ, Romagnolo DF, Selmin OI (2011) Trichloroethylene induces methylation of the Serca2 promoter in H9c2 cells and embryonic heart. Cardiovasc Toxicol 11:204–214PubMedCrossRef Palbykin B, Borg J, Caldwell PT, Rowles J, Papoutsis AJ, Romagnolo DF, Selmin OI (2011) Trichloroethylene induces methylation of the Serca2 promoter in H9c2 cells and embryonic heart. Cardiovasc Toxicol 11:204–214PubMedCrossRef
64.
Zurück zum Zitat Olsgard ML, Bortolotti GR, Trask BR, Smits JE (2008) Effects of inhalation exposure to a binary mixture of benzene and toluene on vitamin a status and humoral and cell-mediated immunity in wild and captive American kestrels. J Toxicol Environ Health 71:1100–1108CrossRef Olsgard ML, Bortolotti GR, Trask BR, Smits JE (2008) Effects of inhalation exposure to a binary mixture of benzene and toluene on vitamin a status and humoral and cell-mediated immunity in wild and captive American kestrels. J Toxicol Environ Health 71:1100–1108CrossRef
65.
Zurück zum Zitat Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT (2004) Hematotoxicity in workers exposed to low levels of benzene. Science 306:1774–1776PubMedCentralPubMedCrossRef Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT (2004) Hematotoxicity in workers exposed to low levels of benzene. Science 306:1774–1776PubMedCentralPubMedCrossRef
66.
Zurück zum Zitat Emara AM, El-Bahrawy H (2008) Green tea attenuates benzene-induced oxidative stress in pump workers. J Immunotoxicol 5:69–80PubMedCrossRef Emara AM, El-Bahrawy H (2008) Green tea attenuates benzene-induced oxidative stress in pump workers. J Immunotoxicol 5:69–80PubMedCrossRef
67.
Zurück zum Zitat Park HJ, Oh JH, Yoon S, Rana SV (2008) Time dependent gene expression changes in the liver of mice treated with benzene. Biomark Insights 3:191–201PubMedCentralPubMed Park HJ, Oh JH, Yoon S, Rana SV (2008) Time dependent gene expression changes in the liver of mice treated with benzene. Biomark Insights 3:191–201PubMedCentralPubMed
68.
Zurück zum Zitat Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA (2004) Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 31:1928–1933PubMed Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA (2004) Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 31:1928–1933PubMed
69.
Zurück zum Zitat De Roos AJ, Cooper GS, Alavanja MC, Sandler DP (2005) Rheumatoid arthritis among women in the agricultural health study: risk associated with farming activities and exposures. Ann Epidemiol 15:762–770PubMedCrossRef De Roos AJ, Cooper GS, Alavanja MC, Sandler DP (2005) Rheumatoid arthritis among women in the agricultural health study: risk associated with farming activities and exposures. Ann Epidemiol 15:762–770PubMedCrossRef
70.
Zurück zum Zitat Su DS, Serafino A, Müller JO, Jentoft RE, Schlögl R, Fiorito S (2008) Cytotoxicity and inflammatory potential of soot particles of low-emission diesel engines. Environ Sci Technol 42:1761–1765PubMedCrossRef Su DS, Serafino A, Müller JO, Jentoft RE, Schlögl R, Fiorito S (2008) Cytotoxicity and inflammatory potential of soot particles of low-emission diesel engines. Environ Sci Technol 42:1761–1765PubMedCrossRef
71.
Zurück zum Zitat Fiorito S, Mastrofrancesco A, Cardinali G, Rosato E, Salsano F, Su DS, Serafino A, Picardo M (2011) Effects of carbonaceous nanoparticles from low-emission and older diesel engines on human skin cells. Carbon 49:5038–5048CrossRef Fiorito S, Mastrofrancesco A, Cardinali G, Rosato E, Salsano F, Su DS, Serafino A, Picardo M (2011) Effects of carbonaceous nanoparticles from low-emission and older diesel engines on human skin cells. Carbon 49:5038–5048CrossRef
72.
Zurück zum Zitat Mastrofrancesco A, Alfè M, Rosato E, Gargiulo V, Beatrice C, Di Blasio G, Zhang B, Su DS, Picardo M, Fiorito S (2014) Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells. J Immunol Res 2014:138751PubMedCentralPubMedCrossRef Mastrofrancesco A, Alfè M, Rosato E, Gargiulo V, Beatrice C, Di Blasio G, Zhang B, Su DS, Picardo M, Fiorito S (2014) Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells. J Immunol Res 2014:138751PubMedCentralPubMedCrossRef
73.
Zurück zum Zitat Aden N, Nuttall A, Shiwen X, de Winter P, Leask A, Black CM, Denton CP, Abraham DJ, Stratton RJ (2010) Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. J Invest Dermatol 130:2191–2200PubMedCrossRef Aden N, Nuttall A, Shiwen X, de Winter P, Leask A, Black CM, Denton CP, Abraham DJ, Stratton RJ (2010) Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. J Invest Dermatol 130:2191–2200PubMedCrossRef
74.
Zurück zum Zitat Chaudhary P, Chen X, Assassi S, Gorlova O, Draeger H, Harper BE, Gonzalez E, McNearney T, Perry M, Arnett FC, Mayes MD (2011) Cigarette smoking is not a risk factor for systemic sclerosis. Arthritis Rheum 63:3098–3102PubMedCentralPubMedCrossRef Chaudhary P, Chen X, Assassi S, Gorlova O, Draeger H, Harper BE, Gonzalez E, McNearney T, Perry M, Arnett FC, Mayes MD (2011) Cigarette smoking is not a risk factor for systemic sclerosis. Arthritis Rheum 63:3098–3102PubMedCentralPubMedCrossRef
75.
Zurück zum Zitat Hissaria P, Roberts-Thomson PJ, Lester S, Ahern MJ, Smith MD, Walker JG (2011) Cigarette smoking in patients with systemic sclerosis reduces overall survival: comment on the article by Hudson et al. Arthritis Rheum 63:1758–1759PubMedCrossRef Hissaria P, Roberts-Thomson PJ, Lester S, Ahern MJ, Smith MD, Walker JG (2011) Cigarette smoking in patients with systemic sclerosis reduces overall survival: comment on the article by Hudson et al. Arthritis Rheum 63:1758–1759PubMedCrossRef
76.
Zurück zum Zitat Hudson M, Lo E, Baron M, Steele R, Canadian Scleroderma Research Group (2011) Modeling smoking in systemic sclerosis: a comparison of different statistical approaches. Arthritis Care Res (Hoboken) 63:570–578CrossRef Hudson M, Lo E, Baron M, Steele R, Canadian Scleroderma Research Group (2011) Modeling smoking in systemic sclerosis: a comparison of different statistical approaches. Arthritis Care Res (Hoboken) 63:570–578CrossRef
77.
Zurück zum Zitat Gyger G, Hudson M, Lo E, Steele R, Canadian Scleroderma Research Group (CSRG), Baron M (2013) Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis? Rheumatol Int 33:943–948PubMedCrossRef Gyger G, Hudson M, Lo E, Steele R, Canadian Scleroderma Research Group (CSRG), Baron M (2013) Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis? Rheumatol Int 33:943–948PubMedCrossRef
78.
Zurück zum Zitat D’Cruz D (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112–113:421–32PubMedCrossRef D’Cruz D (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112–113:421–32PubMedCrossRef
79.
Zurück zum Zitat Haustein UF (2005) Scleroderma and pseudo-scleroderma: uncommon presentations. Clin Dermatol 23:480–490PubMedCrossRef Haustein UF (2005) Scleroderma and pseudo-scleroderma: uncommon presentations. Clin Dermatol 23:480–490PubMedCrossRef
80.
81.
Zurück zum Zitat Vergne P, Bertin P, Bonnet C, Scotto C, Trèves R (2000) Drug-induced rheumatic disorders: incidence, prevention and management. Drug Saf 23:279–293PubMedCrossRef Vergne P, Bertin P, Bonnet C, Scotto C, Trèves R (2000) Drug-induced rheumatic disorders: incidence, prevention and management. Drug Saf 23:279–293PubMedCrossRef
82.
Zurück zum Zitat Lidar M, Agmon-Levin N, Langevitz P, Shoenfeld Y (2012) Silicone and scleroderma revisited. Lupus 21:121–127PubMedCrossRef Lidar M, Agmon-Levin N, Langevitz P, Shoenfeld Y (2012) Silicone and scleroderma revisited. Lupus 21:121–127PubMedCrossRef
83.
Zurück zum Zitat Bridges AJ, Vasey FB (1993) Silicone breast implants. History, safety, and potential complications. Arch Intern Med 153:2638–2644PubMedCrossRef Bridges AJ, Vasey FB (1993) Silicone breast implants. History, safety, and potential complications. Arch Intern Med 153:2638–2644PubMedCrossRef
84.
Zurück zum Zitat Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342:781–790PubMedCrossRef Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342:781–790PubMedCrossRef
85.
Zurück zum Zitat Alexandrescu DT, Bhagwati NS, Wiernik PH (2005) Chemotherapy-induced scleroderma: a pleiomorphic syndrome. Clin Exp Dermatol 30:141–145PubMedCrossRef Alexandrescu DT, Bhagwati NS, Wiernik PH (2005) Chemotherapy-induced scleroderma: a pleiomorphic syndrome. Clin Exp Dermatol 30:141–145PubMedCrossRef
86.
Zurück zum Zitat Beretta L, Caronni M, Vanoli M, Scorza R (2002) Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders. Br J Dermatol 147:385–386PubMedCrossRef Beretta L, Caronni M, Vanoli M, Scorza R (2002) Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders. Br J Dermatol 147:385–386PubMedCrossRef
87.
Zurück zum Zitat Hallé O, Schaeverbeke T, Bannwarth B, Dehais J (1997) Les facteurs d’environnement et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la littérature. Rev Med Interne 18:219–229PubMedCrossRef Hallé O, Schaeverbeke T, Bannwarth B, Dehais J (1997) Les facteurs d’environnement et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la littérature. Rev Med Interne 18:219–229PubMedCrossRef
88.
Zurück zum Zitat Läuchli S, Trüeb RM, Fehr M, Hafner J (2002) Scleroderma-like drug reaction to paclitaxel (Taxol). Br J Dermatol 147:619–621PubMedCrossRef Läuchli S, Trüeb RM, Fehr M, Hafner J (2002) Scleroderma-like drug reaction to paclitaxel (Taxol). Br J Dermatol 147:619–621PubMedCrossRef
89.
Zurück zum Zitat Marie I, Levesque H, Plissonnier D, Balguerie X, Cailleux N, Courtois H (2000) Digital necrosis related to cisplatin in systemic sclerosis. Br J Dermatol 142:833–834PubMedCrossRef Marie I, Levesque H, Plissonnier D, Balguerie X, Cailleux N, Courtois H (2000) Digital necrosis related to cisplatin in systemic sclerosis. Br J Dermatol 142:833–834PubMedCrossRef
90.
Zurück zum Zitat Marie I, Joly P, Courville P, Levesqsue H (2007) Pseudosystemic sclerosis as a complication of recombinant human interleukin 2 (aldesleukin) therapy. Br J Dermatol 156:182–183PubMedCrossRef Marie I, Joly P, Courville P, Levesqsue H (2007) Pseudosystemic sclerosis as a complication of recombinant human interleukin 2 (aldesleukin) therapy. Br J Dermatol 156:182–183PubMedCrossRef
91.
Zurück zum Zitat Vial T, Choquet-Kastylevsky G, Descotes J (2002) Adverse effects of immunotherapeutics involving the immune system. Toxicology 174:3–11PubMedCrossRef Vial T, Choquet-Kastylevsky G, Descotes J (2002) Adverse effects of immunotherapeutics involving the immune system. Toxicology 174:3–11PubMedCrossRef
93.
Zurück zum Zitat Haustein UF, Haupt B (1998) Drug-induced scleroderma and sclerodermiform conditions. Clin Dermatol 16:353–366PubMedCrossRef Haustein UF, Haupt B (1998) Drug-induced scleroderma and sclerodermiform conditions. Clin Dermatol 16:353–366PubMedCrossRef
94.
Zurück zum Zitat Pang BK, Munro V, Kossard S (1996) Pseudoscleroderma secondary to phytomenadione (vitamin K1) injections: Texier’s disease. Australas J Dermatol 37:44–47PubMedCrossRef Pang BK, Munro V, Kossard S (1996) Pseudoscleroderma secondary to phytomenadione (vitamin K1) injections: Texier’s disease. Australas J Dermatol 37:44–47PubMedCrossRef
95.
96.
Zurück zum Zitat Guis S, Mattéi JP, Lioté F (2003) Drug-induced and toxic myopathies. Best Pract Res Clin Rheumatol 17:877–907PubMedCrossRef Guis S, Mattéi JP, Lioté F (2003) Drug-induced and toxic myopathies. Best Pract Res Clin Rheumatol 17:877–907PubMedCrossRef
97.
Zurück zum Zitat Hertzman PA, Clauw DJ, Kaufman LD, Varga J, Silver RM, Thacker HL, Mease P, Espinoza LR, Pincus T (1995) The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Ann Intern Med 122:851–855PubMedCrossRef Hertzman PA, Clauw DJ, Kaufman LD, Varga J, Silver RM, Thacker HL, Mease P, Espinoza LR, Pincus T (1995) The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Ann Intern Med 122:851–855PubMedCrossRef
98.
Zurück zum Zitat Skouby AP (1949) Sclerodermia-like picture following a single serum injection. Acta Med Scand 136:51–55PubMedCrossRef Skouby AP (1949) Sclerodermia-like picture following a single serum injection. Acta Med Scand 136:51–55PubMedCrossRef
99.
Zurück zum Zitat Grossman C, Dovrish Z, Shoenfeld Y, Amital H (2011) Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev 10:244–247PubMedCrossRef Grossman C, Dovrish Z, Shoenfeld Y, Amital H (2011) Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev 10:244–247PubMedCrossRef
100.
Zurück zum Zitat Ferri C, Longombardo G, Azzi A, Zakrzewska K (1999) Parvovirus B19 and systemic sclerosis. Clin Exp Rheumatol 17:267–268PubMed Ferri C, Longombardo G, Azzi A, Zakrzewska K (1999) Parvovirus B19 and systemic sclerosis. Clin Exp Rheumatol 17:267–268PubMed
101.
Zurück zum Zitat Yoto Y, Kudoh T, Haseyama K, Suzuki N, Oda T, Katoh T, Takahashi T, Sekiguchi S, Chiba S (1995) Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 91:1017–1018PubMedCrossRef Yoto Y, Kudoh T, Haseyama K, Suzuki N, Oda T, Katoh T, Takahashi T, Sekiguchi S, Chiba S (1995) Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 91:1017–1018PubMedCrossRef
102.
Zurück zum Zitat Ferri C, Zakrzewska K, Longombardo G, Giuggioli D, Storino FA, Pasero G, Azzi A (1999) Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 17:718–720PubMed Ferri C, Zakrzewska K, Longombardo G, Giuggioli D, Storino FA, Pasero G, Azzi A (1999) Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 17:718–720PubMed
103.
Zurück zum Zitat Cassinotti P, Burtonboy G, Fopp M, Siegl G (1997) Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53:229–232PubMedCrossRef Cassinotti P, Burtonboy G, Fopp M, Siegl G (1997) Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53:229–232PubMedCrossRef
104.
Zurück zum Zitat Magro CM, Nuovo G, Ferri C, Crowson AN, Giuggioli D, Sebastiani M (2004) Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 31:43–50PubMedCrossRef Magro CM, Nuovo G, Ferri C, Crowson AN, Giuggioli D, Sebastiani M (2004) Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 31:43–50PubMedCrossRef
105.
Zurück zum Zitat Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F (1999) Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73:8762–8770PubMedCentralPubMed Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F (1999) Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73:8762–8770PubMedCentralPubMed
106.
Zurück zum Zitat Ferri C, Giuggioli D, Sebastiani M, Panfilo S, Abatangelo G, Zakrzewska K, Azzi A (2002) Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients: comment on the article by Ray et al. Arthritis Rheum 46:2262–2263, author reply 2263–4 PubMedCrossRef Ferri C, Giuggioli D, Sebastiani M, Panfilo S, Abatangelo G, Zakrzewska K, Azzi A (2002) Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients: comment on the article by Ray et al. Arthritis Rheum 46:2262–2263, author reply 2263–4 PubMedCrossRef
107.
Zurück zum Zitat Pandey JP, LeRoy EC (1998) Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum 41:10–15PubMedCrossRef Pandey JP, LeRoy EC (1998) Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum 41:10–15PubMedCrossRef
108.
Zurück zum Zitat Vaughan JH, Shaw PX, Nguyen MD, Medsger TA Jr, Wright TM, Metcalf JS, Leroy EC (2000) Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol 27:821–823PubMed Vaughan JH, Shaw PX, Nguyen MD, Medsger TA Jr, Wright TM, Metcalf JS, Leroy EC (2000) Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol 27:821–823PubMed
109.
Zurück zum Zitat Shahgasempour S, Woodroffe SB, Sullivan-Tailyour G, Garnett HM (1997) Alteration in the expression of endothelial cell integrin receptors alpha 5 beta 1 and alpha 2 beta 1 and alpha 6 beta 1 after in vitro infection with a clinical isolate of human cytomegalovirus. Arch Virol 142:125–138PubMedCrossRef Shahgasempour S, Woodroffe SB, Sullivan-Tailyour G, Garnett HM (1997) Alteration in the expression of endothelial cell integrin receptors alpha 5 beta 1 and alpha 2 beta 1 and alpha 6 beta 1 after in vitro infection with a clinical isolate of human cytomegalovirus. Arch Virol 142:125–138PubMedCrossRef
111.
Zurück zum Zitat Danese S, Zoli A, Cremonini F, Gasbarrini A (2000) High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol 27:1568–1569PubMed Danese S, Zoli A, Cremonini F, Gasbarrini A (2000) High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol 27:1568–1569PubMed
112.
Zurück zum Zitat Kalabay L, Fekete B, Czirják L, Horváth L, Daha MR, Veres A, Fónyad G, Horváth A, Viczián A, Singh M, Hoffer I, Füst G, Romics L, Prohászka Z (2002) Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7:250–256PubMedCrossRef Kalabay L, Fekete B, Czirják L, Horváth L, Daha MR, Veres A, Fónyad G, Horváth A, Viczián A, Singh M, Hoffer I, Füst G, Romics L, Prohászka Z (2002) Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7:250–256PubMedCrossRef
113.
Zurück zum Zitat Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K (1998) High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 25:650–653PubMed Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K (1998) High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 25:650–653PubMed
114.
Zurück zum Zitat Radić M, Martinović Kaliterna D, Bonacin D, Morović Vergles J, Radić J (2010) Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 49:1784–1785CrossRef Radić M, Martinović Kaliterna D, Bonacin D, Morović Vergles J, Radić J (2010) Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 49:1784–1785CrossRef
115.
Zurück zum Zitat Macchia G, Massone A, Burroni D, Covacci A, Censini S, Rappuoli R (1993) The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases. Mol Microbiol 9:645–652PubMedCrossRef Macchia G, Massone A, Burroni D, Covacci A, Censini S, Rappuoli R (1993) The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases. Mol Microbiol 9:645–652PubMedCrossRef
116.
Zurück zum Zitat Alonso-Ruiz A, Calabozo M, Perez-Ruiz F, Mancebo L (1993) Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine (Baltimore) 72:285–295CrossRef Alonso-Ruiz A, Calabozo M, Perez-Ruiz F, Mancebo L (1993) Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine (Baltimore) 72:285–295CrossRef
117.
Zurück zum Zitat Marie I (2008) Connectivites et pseudo-connectivites d’origine médicamenteuse et toxique. In: Rousset H, Vital Durand D, Dupond JL, Pavic M (eds) Diagnostics difficiles en Médecine interne, 3rd edn. Maloine, Paris, pp 179–196 Marie I (2008) Connectivites et pseudo-connectivites d’origine médicamenteuse et toxique. In: Rousset H, Vital Durand D, Dupond JL, Pavic M (eds) Diagnostics difficiles en Médecine interne, 3rd edn. Maloine, Paris, pp 179–196
118.
Zurück zum Zitat Posada de la Paz M, Philen RM, Borda AI (2001) Toxic oil syndrome: the perspective after 20 years. Epidemiol Rev 23:231–247PubMedCrossRef Posada de la Paz M, Philen RM, Borda AI (2001) Toxic oil syndrome: the perspective after 20 years. Epidemiol Rev 23:231–247PubMedCrossRef
119.
Zurück zum Zitat Allen JA, Peterson A, Sufit R, Hinchcliff ME, Mahoney JM, Wood TA, Miller FW, Whitfield ML, Varga J (2011) Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum 63:3633–3639PubMedCrossRef Allen JA, Peterson A, Sufit R, Hinchcliff ME, Mahoney JM, Wood TA, Miller FW, Whitfield ML, Varga J (2011) Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum 63:3633–3639PubMedCrossRef
121.
Zurück zum Zitat Marie I (2014) Sclérodermie systémique et exposition professionnelle : vers une extension de la reconnaissance de maladie professionnelle en 2014 ? Rev Med Interne 35:631–635PubMedCrossRef Marie I (2014) Sclérodermie systémique et exposition professionnelle : vers une extension de la reconnaissance de maladie professionnelle en 2014 ? Rev Med Interne 35:631–635PubMedCrossRef
Metadaten
Titel
Environmental risk factors of systemic sclerosis
verfasst von
Isabelle Marie
Jean-François Gehanno
Publikationsdatum
01.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Seminars in Immunopathology / Ausgabe 5/2015
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-015-0507-3

Weitere Artikel der Ausgabe 5/2015

Seminars in Immunopathology 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.